271 related articles for article (PubMed ID: 21205865)
1. Regulation of E2Fs and senescence by PML nuclear bodies.
Vernier M; Bourdeau V; Gaumont-Leclerc MF; Moiseeva O; Bégin V; Saad F; Mes-Masson AM; Ferbeyre G
Genes Dev; 2011 Jan; 25(1):41-50. PubMed ID: 21205865
[TBL] [Abstract][Full Text] [Related]
2. The retinoblastoma protein and PML collaborate to organize heterochromatin and silence E2F-responsive genes during senescence.
Talluri S; Dick FA
Cell Cycle; 2014; 13(4):641-51. PubMed ID: 24351540
[TBL] [Abstract][Full Text] [Related]
3. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
[TBL] [Abstract][Full Text] [Related]
4. Complete senescence: RB and PML share the task.
Vernier M; Ferbeyre G
Cell Cycle; 2014; 13(5):696. PubMed ID: 24526117
[No Abstract] [Full Text] [Related]
5. PML links aberrant cytokine signaling and oncogenic stress to cellular senescence.
Bourdeau V; Baudry D; Ferbeyre G
Front Biosci (Landmark Ed); 2009 Jan; 14(2):475-85. PubMed ID: 19273079
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways.
Bischof O; Nacerddine K; Dejean A
Mol Cell Biol; 2005 Feb; 25(3):1013-24. PubMed ID: 15657429
[TBL] [Abstract][Full Text] [Related]
7. Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci.
Ye X; Zerlanko B; Zhang R; Somaiah N; Lipinski M; Salomoni P; Adams PD
Mol Cell Biol; 2007 Apr; 27(7):2452-65. PubMed ID: 17242198
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.
Hubackova S; Novakova Z; Krejcikova K; Kosar M; Dobrovolna J; Duskova P; Hanzlikova H; Vancurova M; Barath P; Bartek J; Hodny Z
Cell Cycle; 2010 Aug; 9(15):3085-99. PubMed ID: 20699642
[TBL] [Abstract][Full Text] [Related]
9. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
[TBL] [Abstract][Full Text] [Related]
10. Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence.
Mallette FA; Goumard S; Gaumont-Leclerc MF; Moiseeva O; Ferbeyre G
Oncogene; 2004 Jan; 23(1):91-9. PubMed ID: 14712214
[TBL] [Abstract][Full Text] [Related]
11. Regulation of PML-dependent transcriptional repression by pRB and low penetrance pRB mutants.
Fang W; Mori T; Cobrinik D
Oncogene; 2002 Aug; 21(36):5557-65. PubMed ID: 12165854
[TBL] [Abstract][Full Text] [Related]
12. The ING1a tumor suppressor regulates endocytosis to induce cellular senescence via the Rb-E2F pathway.
Rajarajacholan UK; Thalappilly S; Riabowol K
PLoS Biol; 2013; 11(3):e1001502. PubMed ID: 23472054
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor PML specifically accumulates at RPA/Rad51-containing DNA damage repair foci but is nonessential for DNA damage-induced fibroblast senescence.
Münch S; Weidtkamp-Peters S; Klement K; Grigaravicius P; Monajembashi S; Salomoni P; Pandolfi PP; Weißhart K; Hemmerich P
Mol Cell Biol; 2014 May; 34(10):1733-46. PubMed ID: 24615016
[TBL] [Abstract][Full Text] [Related]
14. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
15. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
16. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
Wolyniec K; Shortt J; de Stanchina E; Levav-Cohen Y; Alsheich-Bartok O; Louria-Hayon I; Corneille V; Kumar B; Woods SJ; Opat S; Johnstone RW; Scott CL; Segal D; Pandolfi PP; Fox S; Strasser A; Jiang YH; Lowe SW; Haupt S; Haupt Y
Blood; 2012 Jul; 120(4):822-32. PubMed ID: 22689861
[TBL] [Abstract][Full Text] [Related]
17. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.
Pearson M; Carbone R; Sebastiani C; Cioce M; Fagioli M; Saito S; Higashimoto Y; Appella E; Minucci S; Pandolfi PP; Pelicci PG
Nature; 2000 Jul; 406(6792):207-10. PubMed ID: 10910364
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
19. Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence.
Martin N; Benhamed M; Nacerddine K; Demarque MD; van Lohuizen M; Dejean A; Bischof O
EMBO J; 2012 Jan; 31(1):95-109. PubMed ID: 22002537
[TBL] [Abstract][Full Text] [Related]
20. Deconstructing PML-induced premature senescence.
Bischof O; Kirsh O; Pearson M; Itahana K; Pelicci PG; Dejean A
EMBO J; 2002 Jul; 21(13):3358-69. PubMed ID: 12093737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
